Study Stopped
sponsor discontinued
Safety and Efficacy of Formulation for Improving Vagina Laxity: A Pilot Study
1 other identifier
interventional
18
1 country
1
Brief Summary
This study is conducted to investigate the safety and efficacy of the formulation containing stem cell secretome and licorice root extract in improving vagina laxity (VL) condition of women in Malaysia. This formulation may stimulate cell rejuvenation and trigger cell renewal efficiently as they contained rich mixture of natural, bioavailable polypeptides and plant extracts and these might help improving the VL condition in women. The study duration is 5 weeks and vagina assessment will be carried out at baseline, week 2 and week 5.The main objectives of this study are:
- 1.To assess the vagina laxity of women in Malaysia after using the formulation.
- 2.To observe any adverse effect occurrence with the use of the formulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Dec 2023
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedMarch 6, 2026
March 1, 2026
11 months
January 13, 2023
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in vagina laxity condition from baseline and at week 2 and week 5 after using the product
Vagina laxity questionnaire (VLQ) will be used to assess participant's vagina laxity conditions at baseline, week 2 and week 5. This is a self-reported tool where participants will be asking to score their vagina laxity on a scale of 1 to 7 (1= very loose, 2= moderately loose, 3= slightly loose, 4= neither tight nor loose, 5= very tight, 6= moderately tight, 7= very tight)
Baseline, Week 2 and Week 5
Change in vagina tone from baseline and at week 2 and week 5 after using the product
Vagina tone is measured using a perineometer (measurement of vaginal squeeze pressure). This assessment will be carried out by trained clinician at baseline, week 2 and week 5 and it will determine participant vagina tone.
Baseline, Week 2 and Week 5
Adverse effect after using the formulation
Based on adverse effect occurrence on participants that occur during study period (5 weeks)
week 5
Study Arms (1)
Formulation X
EXPERIMENTALParticipants will use the formulation once every 72 hour for 5 weeks
Interventions
This formulation containing stem cell secretome and liquorice root extract
Eligibility Criteria
You may qualify if:
- Malaysian women ( age 40 to 55 years old)
- Complaint of vagina laxity
- Willingness to participate in the study
You may not qualify if:
- Pregnant and breastfeeding women
- Doing any surgical or non-surgical procedures to improved vaginal laxity condition such as laser and radiofrequency before participating in the study that might affect the study outcome
- Presence of illness or taking any medication that might impact the study outcome or participants well-being
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Petaling Jaya, Selangor, 47810, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2023
First Posted
February 2, 2023
Study Start
December 1, 2023
Primary Completion
October 31, 2024
Study Completion
December 30, 2024
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share